Delivery Order SPE2DB22D2006-SPE2DB24FW3CU

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $125K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of medical commodities. The $33,057.50 firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines. The contract does not have a set-aside designation and is intended to...
This federal contract award, valued at $5,371.68, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565500700 - MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with an ultimate completion date of August 20, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside used. Amerisourcebergen is a major supplier of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $39,575.25 firm-fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,305.75 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts by...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, over a period ending on June 28, 2024. The award has a ceiling value of $1,173.53 and is a firm fixed-price delivery order contract. The contract was awarded without any set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $8,554.04 Firm Fixed Price Delivery Order is for the supply of 4565585399 MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award, with a ceiling value of $171,290.27, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with an ultimate completion date of August 5, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical and...
This federal contract award, valued at $18,265.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of September 13, 2024. This is a firm-fixed-price delivery order contract, which indicates that Amerisourcebergen will provide the specified medical product at a predetermined price. Amerisourcebergen is a major...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) is a delivery order valued at $81,957.60 for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $30,442.50 firm-fixed-price contract is for the supply of 4565284403 MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3CU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $124,814.25, is for the delivery of 4565585205 MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which are pharmaceutical products. The contract has no set-aside designation and is a firm fixed-price agreement. This contract is part of Amerisourcebergen's larger portfolio of federal contracts and IDCs, which enable the company to efficiently provide a wide range of essential pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen's extensive distribution network and status as one of the largest pharmaceutical distributors in the U.S. make it a key supplier for the Department of Defense and other federal healthcare agencies.

Generated 11/25/24, 9:24 AM